This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nagano, N. Articles by Arakawa, Y. Search for Related Content PubMed PubMed Citation Articles by Nagano, N. Articles by Arakawa, Y.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, September 2004, p. 3978-3984, Vol. 42, No. 9
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.9.3978-3984.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Nosocomial Transmission of CTX-M-2 ß-Lactamase-Producing Acinetobacter baumannii in a Neurosurgery Ward

Medical Microbiology Laboratory, Funabashi Medical Center, Chiba,¹ Department of Bacterial Pathogenesis and Infection Control, National Institute of Infectious Diseases, Tokyo, Japan,³ Molecular Typing Center, Institut Pasteur de Lille, Lille, France²

Received 15 December 2003/ Returned for modification 22 January 2004/ Accepted 13 May 2004

Three strains of cefotaxime (CTX)-resistant Acinetobacter baumannii, FM0209680, FM0300106, and FM0301433, were isolated from transtracheal aspirate cultures of three patients with probable nosocomial infections in a neurosurgery ward in Japan. The CTX MICs for these isolates were greater than 128 µg/ml but were drastically reduced in the presence of 4 µg of clavulanic acid per ml. These strains were also resistant to ceftriaxone, cefpodoxime, and aztreonam but were susceptible to ceftazidime and imipenem. The profile of resistance to various broad-spectrum ß-lactams was transferred by conjugation. Strain FM0209680 was not eradicated from case patient 1 by administration of imipenem, ceftazidime, and levofloxacin, even after a 6-month hospitalization period. Strains FM0300106 and FM0301433 were isolated from case patients 2 and 3 during the sixth week following admission, respectively, and then each patient was colonized for 3 weeks. Eradication of FM0300106 was successfully obtained from case patient 2 by imipenem treatment, while administration of imipenem was continued to prevent pneumonia. Prophylactic antimicrobial therapy was discontinued in case patient 3 because of the lack of pneumonic symptoms, and FM0301433 disappeared after the discontinuation of antimicrobial chemotherapy. All three strains carried the bla_CTX-M-2 gene, and the appearance of colonies in the growth-inhibitory zones around disks of CTX and aztreonam in double-disk synergy tests suggested inducible ß-lactamase production in these A. baumannii strains. The ribotyping investigation suggested that all these strains belong to the same clonal lineage. The plasmids harbored by A. baumannii had the same restriction profile as those harbored by Proteus mirabilis strains previously isolated in a urology ward of the Funabashi Medical Center.

This article has been cited by other articles:

• Valentine, S. C., Contreras, D., Tan, S., Real, L. J., Chu, S., Xu, H. H. (2008). Phenotypic and Molecular Characterization of Acinetobacter baumannii Clinical Isolates from Nosocomial Outbreaks in Los Angeles County, California. J. Clin. Microbiol. 46: 2499-2507 [Abstract] [Full Text]  
• Peleg, A. Y., Seifert, H., Paterson, D. L. (2008). Acinetobacter baumannii: Emergence of a Successful Pathogen. Clin. Microbiol. Rev. 21: 538-582 [Abstract] [Full Text]  
• Kawamura-Sato, K., Wachino, J.-i., Kondo, T., Ito, H., Arakawa, Y. (2008). Reduction of disinfectant bactericidal activities in clinically isolated Acinetobacter species in the presence of organic material. J Antimicrob Chemother 61: 568-576 [Abstract] [Full Text]  
• Nagano, N., Cordevant, C., Nagano, Y. (2008). Upper and lower urinary tract infection caused by Klebsiella pneumoniae serotype K2 and CTX-M-15 -lactamase-producing serotype K1: a case report and characterization of serum killing resistance. J Med Microbiol 57: 121-124 [Abstract] [Full Text]  
• Perez, F., Hujer, A. M., Hujer, K. M., Decker, B. K., Rather, P. N., Bonomo, R. A. (2007). Global Challenge of Multidrug-Resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 51: 3471-3484 [Full Text]  
• Endimiani, A., Luzzaro, F., Migliavacca, R., Mantengoli, E., Hujer, A. M., Hujer, K. M., Pagani, L., Bonomo, R. A., Rossolini, G. M., Toniolo, A. (2007). Spread in an Italian Hospital of a Clonal Acinetobacter baumannii Strain Producing the TEM-92 Extended-Spectrum {beta}-Lactamase. Antimicrob. Agents Chemother. 51: 2211-2214 [Abstract] [Full Text]  
• al Naiemi, N., Duim, B., Bart, A. (2006). A CTX-M extended-spectrum {beta}-lactamase in Pseudomonas aeruginosa and Stenotrophomonas maltophilia.. J Med Microbiol 55: 1607-1608 [Full Text]  
• Naas, T., Bogaerts, P., Bauraing, C., Degheldre, Y., Glupczynski, Y., Nordmann, P. (2006). Emergence of PER and VEB extended-spectrum {beta}-lactamases in Acinetobacter baumannii in Belgium. J Antimicrob Chemother 58: 178-182 [Abstract] [Full Text]  
• Shibata, N., Kurokawa, H., Doi, Y., Yagi, T., Yamane, K., Wachino, J.-i., Suzuki, S., Kimura, K., Ishikawa, S., Kato, H., Ozawa, Y., Shibayama, K., Kai, K., Konda, T., Arakawa, Y. (2006). PCR Classification of CTX-M-Type {beta}-Lactamase Genes Identified in Clinically Isolated Gram-Negative Bacilli in Japan. Antimicrob. Agents Chemother. 50: 791-795 [Abstract] [Full Text]  
• Welsh, K. J., Barlow, M., Tenover, F. C., Biddle, J. W., Rasheed, J. K., Clark, L. A., McGowan, J. E. Jr. (2005). Experimental Prediction of the Evolution of Ceftazidime Resistance in the CTX-M-2 Extended-Spectrum Beta-Lactamase. Antimicrob. Agents Chemother. 49: 1242-1244 [Abstract] [Full Text]  
• Linscott, A. J., Brown, W. J. (2005). Evaluation of Four Commercially Available Extended-Spectrum Beta-Lactamase Phenotypic Confirmation Tests. J. Clin. Microbiol. 43: 1081-1085 [Abstract] [Full Text]